CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
63 hedge funds and large institutions have $50.2M invested in CASI Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
38% less capital invested
Capital invested by funds: $80.8M → $50.2M (-$30.6M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
63
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.33M | |
| 2 | +$1.25M | |
| 3 | +$1.21M | |
| 4 |
BlackRock
New York
|
+$1.01M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$423K |
Top Sellers
| 1 | -$383K | |
| 2 | -$378K | |
| 3 | -$288K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$188K |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
-$187K |